Volume 9, Issue 2 (2023)
IEM 2023, 9(2): 191-199 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Zahoor D, Farhana A, Manzoor M, Kanth F, Nasir R. Detection of Mycobacterium tuberculosis in Pulmonary and Extrapulmonary Samples Using Different Methods: Experience of a Tertiary Care Center in North India. IEM 2023; 9 (2) :191-199
URL: http://iem.modares.ac.ir/article-4-64223-en.html
URL: http://iem.modares.ac.ir/article-4-64223-en.html
1- Department of Microbiology Government Medical College, Srinagar J&K, India , danish762@gmail.com
2- Department of Microbiology Government Medical College, Srinagar J&K, India
3- Lecturer Department of Microbiology Government Medical College, Srinagar J&K, India
4- Department of Microbiology Government Medical College, Srinagar
2- Department of Microbiology Government Medical College, Srinagar J&K, India
3- Lecturer Department of Microbiology Government Medical College, Srinagar J&K, India
4- Department of Microbiology Government Medical College, Srinagar
Abstract: (671 Views)
Backgrounds: Delay in the diagnosis of tuberculosis (TB) leads to poor response to treatment and the disease transmission to susceptible individuals. The Xpert MTB/RIF assay efficiently detects Mycobacterium tuberculosis (MTB). The present study aimed to compare acid-fast bacilli (AFB) microscopy, culture, and Xpert MTB/RIF assay in the diagnosis of pulmonary and extrapulmonary tuberculosis cases.
Materials & Methods: This retrospective study was conducted in the Department of Microbiology, Government Medical College, Srinagar, India over 18 months from February 2019 to July 2020. Samples were processed and evaluated using AFB microscopy, culture, and Xpert MTB/RIF assay.
Findings: Among the 1862 samples evaluated, 224 samples were found to be positive using AFB microscopy, culture, and Xpert MTB/RIF assay. The overall sensitivity and specificity of the Xpert MTB/RIF assay in diagnosing pulmonary TB cases was 98.23 and 97.69%, respectively. Among the smear-negative extrapulmonary samples, 52 (5.75%) and 86 (9.6%) samples were positive in culture and the Xpert MTB/RIF assay, respectively. The maximum recovery of MTB by Xpert MTB/RIF assay was from tissue biopsy specimens. Rifampicin resistance was observed in six samples.
Conclusion: Both culture and Xpert MTB/RIF methods were sensitive in detecting smear-positive samples. Although both techniques missed some smear-negative pulmonary and extrapulmonary TB cases, the Xpert MTB/RIF assay enhanced the detection rate of MTB compared to culture. The Xpert MTB/RIF assay enabled the accurate diagnosis of tuberculosis cases with a rapid turnaround time; therefore, it could assist clinicians to start timely therapeutic interventions for these patients.
Materials & Methods: This retrospective study was conducted in the Department of Microbiology, Government Medical College, Srinagar, India over 18 months from February 2019 to July 2020. Samples were processed and evaluated using AFB microscopy, culture, and Xpert MTB/RIF assay.
Findings: Among the 1862 samples evaluated, 224 samples were found to be positive using AFB microscopy, culture, and Xpert MTB/RIF assay. The overall sensitivity and specificity of the Xpert MTB/RIF assay in diagnosing pulmonary TB cases was 98.23 and 97.69%, respectively. Among the smear-negative extrapulmonary samples, 52 (5.75%) and 86 (9.6%) samples were positive in culture and the Xpert MTB/RIF assay, respectively. The maximum recovery of MTB by Xpert MTB/RIF assay was from tissue biopsy specimens. Rifampicin resistance was observed in six samples.
Conclusion: Both culture and Xpert MTB/RIF methods were sensitive in detecting smear-positive samples. Although both techniques missed some smear-negative pulmonary and extrapulmonary TB cases, the Xpert MTB/RIF assay enhanced the detection rate of MTB compared to culture. The Xpert MTB/RIF assay enabled the accurate diagnosis of tuberculosis cases with a rapid turnaround time; therefore, it could assist clinicians to start timely therapeutic interventions for these patients.
Keywords: Pulmonary tuberculosis, Extrapulmonary tuberculosis, Diagnosis, Sensitivity and specificity
Article Type: Original Research |
Subject:
Bacteriology
Received: 2022/09/16 | Accepted: 2023/06/15 | Published: 2023/08/19
Received: 2022/09/16 | Accepted: 2023/06/15 | Published: 2023/08/19
References
1. 1. Zeka AN, Tasbakan S, Cavusoglu C. Evaluation of the GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampin resistance in pulmonary and extrapulmonary specimens. J Clin Microbiol. 2011;49(12):4138-41. [DOI:10.1128/JCM.05434-11] [PMID] []
2. World Health Organization. Global tuberculosis report. Geneva: World Health Organization; 2021.
3. Vadwai V, Boehme C, Nabeta P, Shetty A, Alland D, Rodrigues C. Xpert MTB/RIF: A new pillar in diagnosis of extrapulmonary tuberculosis? J Clin Microbiol. 2011;49(7):2540-5. [DOI:10.1128/JCM.02319-10] [PMID] []
4. Zahoor D, Wani S, Wani ZN. Evaluation of cepheid GeneXpert MTB/RIF assay for Mycobacterium tuberculosis detection and rifampicin resistance in clinical specimens. Int J Res Med Sci. 2019;7(6):2121-6. [DOI:10.18203/2320-6012.ijrms20192484]
5. Opota O, Greub G, Jaton K. The rapid molecular test Xpert MTB/RIF Ultra: Towards improved tuberculosis diagnosis and rifampicin resistance detection. Clin Microbiol Infect. 2019;25(11):1370-6. [DOI:10.1016/j.cmi.2019.03.021]
6. Lombardi G, Di Gregori V, Girometti N, Tadolini M, Bisognin F, Dal Monte P. Diagnosis of smear-negative tuberculosis is greatly improved by Xpert MTB/RIF. PLoS One. 2017;12(4):e0176186. [DOI:10.1371/journal.pone.0176186] []
7. Rakotosamimanana N, Lapierre SG, Raharimanga V, Raherison MS, Knoblauch AM, Raherinandrasana AH, et al. Performance and impact of GeneXpert MTB/RIF ® and Loopamp MTBC Detection Kit ® assays on tuberculosis case detection in Madagascar. BMC Infect Dis. 2019;19(1):1-8. [DOI:10.1186/s12879-019-4198-6] [PMID] []
8. Qureshi S, Sohaila A, Hannan S, Dawood M, Sheikh A, Qamar FN. Comparison of Xpert MTB/RIF with AFB smear and AFB culture in suspected cases of paediatric tuberculosis in a tertiary care hospital , Karachi. J Pak Med Assoc. 2001;69(9):1273-8.
9. Habous M, Elimam MA, Kumar R, Deesi ZA. Evaluation of GeneXpert Mycobacterium tuberculosis/Rifampin for the detection of Mycobacterium tuberculosis complex and rifampicin resistance in nonrespiratory clinical specimens. Int J Mycobacteriol. 2019;8(2):132-7. [DOI:10.4103/ijmy.ijmy_83_19] [PMID]
10. Kohli M, Schiller I, Dendukuri N, Yao M, Dheda K, Cm D, et al. Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2021;1(1):CD012768. [DOI:10.1002/14651858.CD012768.pub3] [PMID] []
11. Horne DJ, Kohli M, Zifodya JS, Schiller I, Dendukuri N, Tollefson D, et al. Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2019;6(6):CD009593. [DOI:10.1002/14651858.CD009593.pub4] []
12. Oliveira MC, Sant'Anna CC, Luiz R, Soares EC, Kritski AL. Contribution of Xpert MTB/RIF to clinical diagnosis in adolescents with tuberculosis in Rio de Janeiro, Brazil. Int J Tuberc Lung Dis. 2019;23(10):1115-21 [DOI:10.5588/ijtld.18.0778] [PMID]
13. Afsar I. Comparison of culture , microscopic smear, and molecular methods in diagnosis of tuberculosis. Rev Esp Quim. 2018;31(5):435-8.
14. Rasool G, Khan AM, Mohy-ud-din R, Riaz M. Detection of Mycobacterium tuberculosis in AFB smear-negative sputum specimens through MTB culture and GeneXpert ® MTB/RIF assay. Int J Immunopathol Pharmacol. 2019;33:2058738419827174. [DOI:10.1177/2058738419827174] [PMID] []
15. Chien J, Lin C, Yu C, Hsueh P, Lemaitre NC. Usefulness of Xpert MTB/RIF Ultra to rapidly diagnose sputum smear-negative pulmonary tuberculosis using bronchial washing fluid. Front Microbiol. 2020;11:1-7. [DOI:10.3389/fmicb.2020.588963] []
16. Tadesse M, Abebe G, Bekele A, Bezabih M, Yilma D, Apers L, et al. Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: A diagnostic evaluation study. Clin Microbiol Infect. 2019;25(8):1000-5. [DOI:10.1016/j.cmi.2018.12.018] [PMID]
17. Zahoor D, Farhana A, Kanth F, Manzoor M. Evaluation of smear microscopy and GeneXpert for the rapid diagnosis of pulmonary and extrapulmonary tuberculosis in a tertiary care hospital in North India: A descriptive prospective study. Int J Res Med Sci. 2018;6(5):1756-60. [DOI:10.18203/2320-6012.ijrms20181774]
18. Feliciano CS, José L, Menon B, Maria L, Anselmo P, Dippenaar A, et al. Xpert MTB/RIF performance to diagnose tuberculosis and rifampicin resistance in a reference centre in southern Brazil. ERJ Open Res. 2019;5(3):00043-2019. [DOI:10.1183/23120541.00043-2019] [PMID] []
19. Gholoobi A, Masoudi-kazemabad A, Meshkat M, Meshkat Z. Comparison of culture and PCR methods for diagnosis of Mycobacterium tuberculosis in different clinical specimens. Jundishapur J Microbiol. 2014;7(2):e8939. [DOI:10.5812/jjm.8939] [PMID] []
20. Pinyopornpanish K, Chaiwarith R, Pantip C, Keawvichit R, Wongworapat K, Khamnoi P, et al. Comparison of Xpert MTB/RIF assay and the conventional sputum microscopy in detecting Mycobacterium tuberculosis in northern Thailand. Tuberc Res Treat. 2015;2015. [DOI:10.1155/2015/571782] []
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |